- WHATS NEW?
- Suppression of chemokines by HDL
- HDL cholesterol linked to oestrogen levels
- New gene loci regulating HDL cholesterol identified
- Abnormal lipids when young predicts atherosclerosis in later life
- JUPITER: Is HDL cholesterol relevant to residual risk in low-risk patients on potent statin therapy?
- EAS Workshop: How does HDL protect against atherosclerosis?
COMPELL
Combination treatment with low to moderate doses of niacin plus statin provided comprehensive lipid control, superior to potent statin monotherapy or combination statin-ezetimibe therapy.
Corporate sponsor
